CHF and arrhythmias:

Indications for: VYNDAMAX

Treatment in adults with cardiomyopathy of wild type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) to reduce cardiovascular mortality and cardiovascular-related hospitalization.

Adult Dosage:

Swallow whole. 61mg once daily. Not substitutable with Vyndaqel on a per mg basis.

Children Dosage:

Not established.

VYNDAMAX Warnings/Precautions:

Pregnancy. Advise females of reproductive potential to consider pregnancy planning and prevention. Nursing mothers: not recommended.

VYNDAMAX Classification:

Transthyretin (TTR) stabilizer.

VYNDAMAX Interactions:

May potentiate BCRP substrates (eg, methotrexate, rosuvastatin, imatinib).

Generic Drug Availability:


How Supplied: